Neurolysin: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: Reverted mobile edit mobile web edit
No edit summary
Tag: Manual revert
 
Line 29: Line 29:
{{neuroscience-stub}}
{{neuroscience-stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 17:37, 18 March 2025

Neurolysin is a type of enzyme that is encoded in humans by the NLN gene. It is a member of the M3 metallopeptidases family, which are enzymes that use a metal ion in their catalytic mechanism. Neurolysin is found in various tissues in the body, but is particularly concentrated in the brain and nervous system.

Function[edit]

Neurolysin is involved in the degradation of neuropeptides, small protein-like molecules used by neurons to communicate with each other. It is particularly involved in the breakdown of bradykinin, a peptide that causes blood vessels to dilate, and neurotensin, a neuropeptide that functions as a neurotransmitter and neuromodulator.

Clinical significance[edit]

Alterations in the function of neurolysin have been implicated in a number of neurological disorders. For example, decreased activity of neurolysin has been associated with schizophrenia and Alzheimer's disease. In addition, mutations in the NLN gene have been linked to mental retardation.

Research[edit]

Research into neurolysin has focused on its potential as a therapeutic target for the treatment of neurological disorders. Inhibitors of neurolysin, for example, could potentially be used to increase the levels of beneficial neuropeptides in the brain.

See also[edit]

References[edit]

<references group="" responsive="1"></references>

Stub icon
   This article is a enzyme-related stub. You can help WikiMD by expanding it!




Stub icon
   This article is a neuroscience stub. You can help WikiMD by expanding it!